Preventing Addiction Related Suicide (PARS) - Controlled Trial of Secondary Suicide Prevention

预防成瘾相关自杀 (PARS) - 二级自杀预防对照试验

• 批准号: 9926359
• 负责人: KATHERINE ANNE COMTOIS
• 金额: $ 0.85万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-15 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9926359
• 关键词: Address; Administrator; Adult; Alcohol or Other Drugs use; Attitude; Behavior Therapy; Behavioral; Belief; Caring; Client; Clinic; Communities; Country; Data; Development; Dose; Drug abuse; Effectiveness; Enrollment; Evidence based practice; Family; Feeling suicidal; Friends; Goals; Group Therapy; Guidelines; Hour; Individual; Institutes; Intoxication; Knowledge; Mediating; Modality; National Institute of Drug Abuse; Outcome; Participant; Pharmaceutical Preparations; Population; Positioning Attribute; Prevention program; Prevention strategy; Professional counselor; Protocols documentation; Publishing; Randomized; Relapse; Reporting; Research; Research Personnel; Sampling; Substance Use Disorder; Suicide; Suicide attempt; Suicide prevention; Testing; Time; United States Substance Abuse and Mental Health Services Administration; Washington; addiction; alcohol abuse therapy; alcohol use disorder; base; community setting; compare effectiveness; design; effectiveness trial; follow up assessment; follow-up; help-seeking behavior; high risk; high risk population; improved; improved outcome; innovation; model design; multiple drug use; novel; outpatient programs; post intervention; prevent; programs; prospective; psychoeducational; public health relevance; selective prevention; skills; suicidal; suicidal behavior; suicidal risk; treatment as usual; treatment group; treatment site

Project Abstract/Summary Studies consistently show suicide and suicidal behaviors are highly related to substance use disorders (SUDs). Recent reviews find that the risk of suicide is 10-17 times higher for people using multiple drugs, injecting drugs, and for alcohol use disorders. Utilizing clearly established Stage I guidelines for developing and adapting behavioral interventions, as well as information included in a SAMHSA Treatment Improvement Protocol (TIP50) on suicide and addiction, the current Investigators developed the Preventing Addiction Related Suicide (PARS) program by integrating the content of empirically-supported secondary suicide prevention programs. PARS is a psychoeducational program taught as a single 3 hour module integrated into a standard group therapy-oriented Intensive Outpatient Program (IOP), the most common form of community drug abuse treatment.9 PARS was conceptualized and developed with a team of community treatment leaders who advised on its scope, duration, and approach. Community partners reviewed early drafts and all pilot testing was conducted in community treatment settings. Pilot testing of PARS demonstrated significant post- intervention increases in client knowledge of suicide and decreases in maladaptive attitudes toward suicide; both were maintained at 1-month follow-up. The likelihood of positive help seeking to prevent suicide for themselves as well as for a friend and for family all doubled for the month after the program compared to the month before. Given these promising Stage I results in Stage III settings, we propose a fully-powered Stage III effectiveness trial of PARS compared to Treatment-As-Usual (TAU) using a randomized stepped wedge design with 900 clients in 15 community addiction treatment sites in Washington State to replicate the pilot findings and evaluate how the mechanisms of improving accurate information and attitudes about suicide promote help-seeking. This proposal is innovative in its topic and development in community settings as well as its use of a stepped wedge design. Community treatment agencies, by integrating PARS into their IOP group treatment, are in a unique position to act as key players in the national suicide prevention strategy by providing accurate suicide prevention information, improving attitudes toward suicide, and increasing help- seeking skills to one of the most high-risk suicidal populations in the country.

项目摘要/摘要 研究一致表明，自杀和自杀行为与物质使用障碍(SUDS)高度相关。 最近的审查发现，使用多种药物、注射的人自杀的风险要高出10-17倍 药物，以及酒精使用障碍。利用明确制定的第一阶段指导方针制定和实施 适应行为干预，以及SAMHSA治疗改进中包含的信息 关于自杀和成瘾的议定书(TIP50)，目前的研究人员开发了预防成瘾 整合经验性二次自杀内容的相关自杀(PARS)计划 预防计划。PARS是一个心理教育项目，作为一个单独的3小时模块集成到 以团体治疗为导向的标准强化门诊计划(IOP)，最常见的社区形式 药物滥用治疗。9与一个社区治疗领导小组一起构思和制定了9个部分。 世卫组织就其范围、持续时间和方法提出了建议。社区合作伙伴审查了早期草案和所有试点 测试是在社区治疗环境中进行的。PAR的试运行测试显示， 干预增加了患者对自杀的知识，减少了对自杀的不适应态度； 两组均随访1个月。寻求积极帮助以防止自杀的可能性 在项目结束后的一个月里，他们自己以及朋友和家人的收入都比 几个月前。考虑到在第三阶段的设置中这些有希望的第一阶段的结果，我们提议一个完全有动力的第三阶段 使用随机阶梯形楔形物的PARS与常规治疗(TAU)的疗效比较试验 在华盛顿州15个社区戒毒点与900名客户一起设计，以复制试点 发现和评估如何改善关于自杀的准确信息和态度的机制 促进求助。这项建议在主题和社区环境中的发展方面都是创新的 因为它使用了阶梯形楔形设计。社区治疗机构，将PAR整合到他们的眼压中 团体治疗在国家自杀预防战略中处于独特的地位，通过 提供准确的自杀预防信息，改善对自杀的态度，并增加帮助- 向这个国家最有自杀倾向的高危人群之一寻求技能。